⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3824245 | 0.97 | HDAC6 (0.48) | — | |
| SCHEMBL80142 | 0.92 | HDAC1 (0.48) | — | |
| SCHEMBL9419852 | 0.91 | HDAC6 (0.57) | — | |
| SCHEMBL27515517 | 0.89 | HDAC1 (0.47) | — | |
| SCHEMBL28212557 | 0.89 | HDAC1 (0.47) | — | |
| Fluoride SCHEMBL30394298 | 0.89 | HDAC1 (0.47) | — | |
| SCHEMBL27882289 | 0.89 | HDAC1 (0.47) | — | |
| SCHEMBL20510943 | 0.89 | CNR1 (0.47) | — | |
| SCHEMBL27462334 | 0.87 | HDAC1 (0.50) | — | |
| Fluoride SCHEMBL27588272 | 0.85 | HDAC1 (0.48) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 864 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144788-A1 | COMPOUND FOR SHP2 PROTEIN DEGRADATION AND MEDICAL USES THEREOF | UBIX THERAPEUTICS, INC. (KR) | 2026-05-28 | — | — | US | claimed |
| EP-3185329-B1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO LTD (KR) | 2026-04-22 | — | — | EP | claimed |
| US-20250223285-A1 | NOVEL HETEROCYCLIC DERIVATIVES USEFUL AS SHP2 INHIBITORS | JACOBIO PHARMACEUTICALS CO LTD (CN) | 2025-07-10 | — | — | US | claimed |
| CN-120118074-A | PI3K alpha inhibitor compound, pharmaceutical composition and application thereof | 长春金赛药业有限责任公司 | 2025-06-10 | — | — | CN | claimed |
| WO-2025030002-A2 | DGK TARGETING COMPOUNDS AND USES THEREOF | ARVINAS OPERATIONS, INC. (US) | 2025-02-06 | — | — | WO | claimed |
| WO-2024134683-A1 | Novel process for the preparation of intermediate compounds used in the treatment of migraine | MSN LABORATORIES PRIVATE LIMITED, R&D CENTER (IN) | 2024-06-27 | — | — | WO | claimed |
| EP-3185328-B1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO LTD (KR) | 2024-05-22 | — | — | EP | claimed |
| CN-118039263-A | High-voltage cable buffer layer, preparation method thereof and high-voltage cable | 广东电网有限责任公司广州供电局 | 2024-05-14 | — | — | CN | claimed |
| EP-3185332-B1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO LTD (KR) | 2024-05-01 | — | — | EP | claimed |
| CN-117825266-A | Quantitative test method for binding force of fiber coating | 中国科学院苏州纳米技术与纳米仿生研究所 | 2024-04-05 | — | — | CN | claimed |
| WO-2011069134-A2 | SUPPORTED OLEFIN METATHESIS CATALYSTS | MATERIA, INC. (US) | 2011-06-09 | — | — | WO | claimed |
| US-20100152237-A1 | BIS-PYRINDINO CONTAINING COMPOUNDS FOR THE USE IN THE TREATMENT OF CNS PATHOLOGIES | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2010-06-17 | — | — | US | claimed |
| US-7598330-B2 | Cross-metathesis of olefins directly substituted with an electron-withdrawing group using transition metal carbene catalysts | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2009-10-06 | — | — | US | claimed |
| US-20080287490-A1 | Bis-pyridino containing compounds for the use in the treatment of CNS pathologies | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2008-11-20 | — | — | US | claimed |
| EP-1497299-A4 | CROSS-METATHESIS OF OLEFINS DIRECTLY SUBSTITUTED WITH AN ELECTRON-WITHDRAWING GROUP USING TRANSITION METAL CARBENE CATALYSTS | CALIFORNIA INST OF TECHN (US) | 2006-08-02 | — | — | EP | claimed |
| US-20050261334-A1 | Bis-pyridino containing compounds for the use in the treatment of CNS pathologies | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION | 2005-11-24 | — | — | US | claimed |
| EP-1497299-A2 | CROSS-METATHESIS OF OLEFINS DIRECTLY SUBSTITUTED WITH AN ELECTRON-WITHDRAWING GROUP USING TRANSITION METAL CARBENE CATALYSTS | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2005-01-19 | — | — | EP | claimed |
| US-20030236427-A1 | Cross-metathesis of olefins directly substituted with an electron-withdrawing group using transition metal carbene catalysts | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2003-12-25 | — | — | US | claimed |
| US-20030225142-A1 | Chain-modified pyridino-N substituted nicotine compounds for use in the treatment of CNS pathologies | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION | 2003-12-04 | — | — | US | claimed |
| WO-2003087167-A2 | CROSS-METATHESIS OF OLEFINS DIRECTLY SUBSTITUTED WITH AN ELECTRON-WITHDRAWING GROUP USING TRANSITION METAL CARBENE CATALYSTS | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2003-10-23 | — | — | WO | claimed |